---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-159845"
form_type: "8-K"
ticker: "TYRA"
cik: "0001863127"
company_name: "Tyra Biosciences, Inc."
filed_at: "2023-06-02T23:59:59+00:00"
generated_at: "2026-06-14T08:33:16.631755+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Tyra Biosciences stockholders elect three Class II directors, ratify E&Y as auditor

## Summary
- Stockholders elected Isan Chen (37.3M for), Gilla Kaplan (37.6M for), and Robert More (37.6M for) as Class II directors to serve until 2026.
- Ratification of Ernst & Young as independent auditor for FY 2023 passed with 40,984,756 for, 625 against, and 1,819 abstentions.
- Broker non-votes were 3,109,065 for director elections and 0 for auditor ratification.
- Annual meeting held on May 31, 2023; all proposals approved by substantial majorities.

## SEC filing metadata
- accession: 0001193125-23-159845
- form_type: 8-K
- ticker: TYRA
- cik: 0001863127
- company_name: Tyra Biosciences, Inc.
- filed_at: 2023-06-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1863127/000119312523159845/0001193125-23-159845-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1863127/000119312523159845/d509793d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-159845
- JSON: https://secwatch.observer/filing/0001193125-23-159845.json
- Plain text: https://secwatch.observer/filing/0001193125-23-159845.txt

## Key facts
- Shareholder Votes
  Tyra Biosciences, Inc. shareholders approved Election of three Class II directors to serve until the 2026 Annual Meeting of Stockholders at the 2023-05-31 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-05-31
  source text: 1. The election of three directors to serve as Class II directors for a three-year term to expire at the 2026 Annual Meeting of Stockholders. The following three Class II directors were elected by the votes indicated: For Withheld Broker Non-Votes Isan Chen, M.D. 37,336,370 541,765 3,109,065 Gilla Kaplan, Ph.D. 37,581,968 296,167 3,109,065 Robert More 37,571,418 306,717 3,109,065
  evidence_url: https://www.sec.gov/Archives/edgar/data/1863127/000119312523159845/0001193125-23-159845-index.htm
- Shareholder Votes
  Tyra Biosciences, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-05-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-31
  source text: 2. The ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The appointment was ratified by the votes indicated: For Against Abstain Broker Non-Votes 40,984,756 625 1,819 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1863127/000119312523159845/0001193125-23-159845-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.